MedStar Washington Hosp Center — Washington D.C., District of Columbia

MedStar Washington Hosp Center is a clinical research site located in Washington D.C., District of Columbia, United States 20010.

Crixeo Health Trust Score: 65/100 (FAIR). This profile has not yet been claimed by the site owner.

MedStar Washington Hosp Center has participated in 6 clinical trials with 2 currently active.

Therapeutic areas: Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer, Metastatic Breast Cancer, Cytomegalovirus Infections.

Sponsors: Hoffmann-La Roche, Genentech, Inc..

Sponsor Feasibility Report

Trust Score: 65/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MedStar Washington Hosp Center?

MedStar Washington Hosp Center has a Crixeo Trust Score of 65/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MedStar Washington Hosp Center conducted?

MedStar Washington Hosp Center has 6 clinical trials on record, with 2 currently active. Their work covers Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer, Metastatic Breast Cancer, Cytomegalovirus Infections.

Is MedStar Washington Hosp Center accredited by Crixeo Health?

MedStar Washington Hosp Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MedStar Washington Hosp Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.